158 related articles for article (PubMed ID: 18974490)
21. Pattern of Gram-negative bloodstream infections and their antibiotic susceptibility profiles in a neonatal intensive care unit.
Sana F; Satti L; Zaman G; Gardezi A; Imtiaz A; Ahmed A; Khadim MT
J Hosp Infect; 2018 Mar; 98(3):243-244. PubMed ID: 29128348
[No Abstract] [Full Text] [Related]
22. Molecular epidemiology of beta-lactamase producing nosocomial Gram-negative pathogens from North and South Indian hospitals.
Khurana S; Mathur P; Kapil A; Valsan C; Behera B
J Med Microbiol; 2017 Jul; 66(7):999-1004. PubMed ID: 28671522
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Molecular Characteristics of Neonatal Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacteremia: A 12-Year Case-Control-Control Study of a Referral Center in Taiwan.
Tsai MH; Lee IT; Chu SM; Lien R; Huang HR; Chiang MC; Fu RH; Hsu JF; Huang YC
PLoS One; 2016; 11(8):e0159744. PubMed ID: 27505270
[TBL] [Abstract][Full Text] [Related]
24. Rapid detection of extended-spectrum beta-lactamase (ESBL)-producing organisms in blood culture.
Weinbren MJ; Borthwick MA
J Antimicrob Chemother; 2005 Jan; 55(1):131-2. PubMed ID: 15574477
[No Abstract] [Full Text] [Related]
25. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Lu PL; Liu YC; Toh HS; Lee YL; Liu YM; Ho CM; Huang CC; Liu CE; Ko WC; Wang JH; Tang HJ; Yu KW; Chen YS; Chuang YC; Xu Y; Ni Y; Chen YH; Hsueh PR
Int J Antimicrob Agents; 2012 Jun; 40 Suppl():S37-43. PubMed ID: 22749057
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum beta-lactamase- and metallo-beta-lactamase-producing Gram-negative bacteria--an Indian experience.
Azim A; Dwivedi M; Rao PB; Baronia AK; Singh RK; Prasad KN; Poddar B; Mishra A; Gurjar M; Dhole TN
J Med Microbiol; 2010 Aug; 59(Pt 8):955-960. PubMed ID: 20413621
[TBL] [Abstract][Full Text] [Related]
27. Neonatal septicemia isolates and resistance patterns in a tertiary care hospital of North India.
Kaistha N; Mehta M; Singla N; Garg R; Chander J
J Infect Dev Ctries; 2009 Nov; 4(1):55-7. PubMed ID: 20130381
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2010-2013.
Jean SS; Coombs G; Ling T; Balaji V; Rodrigues C; Mikamo H; Kim MJ; Rajasekaram DG; Mendoza M; Tan TY; Kiratisin P; Ni Y; Weinman B; Xu Y; Hsueh PR
Int J Antimicrob Agents; 2016 Apr; 47(4):328-34. PubMed ID: 27005459
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterisation of extended-spectrum β-lactamase-producing Gram-negative bacterial isolates from surgical wounds of patients at a hospital in North Central Nigeria.
Olowo-Okere A; Ibrahim YKE; Olayinka BO
J Glob Antimicrob Resist; 2018 Sep; 14():85-89. PubMed ID: 29438821
[TBL] [Abstract][Full Text] [Related]
30. Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase-associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa.
Toy T; Pak GD; Duc TP; Campbell JI; El Tayeb MA; Von Kalckreuth V; Im J; Panzner U; Cruz Espinoza LM; Eibach D; Dekker DM; Park SE; Jeon HJ; Konings F; Mogeni OD; Cosmas L; Bjerregaard-Andersen M; Gasmelseed N; Hertz JT; Jaeger A; Krumkamp R; Ley B; Thriemer K; Kabore LP; Niang A; Raminosoa TM; Sampo E; Sarpong N; Soura A; Owusu-Dabo E; Teferi M; Yeshitela B; Poppert S; May J; Kim JH; Chon Y; Park JK; Aseffa A; Breiman RF; Schütt-Gerowitt H; Aaby P; Adu-Sarkodie Y; Crump JA; Rakotozandrindrainy R; Meyer CG; Sow AG; Clemens JD; Wierzba TF; Baker S; Marks F
Clin Infect Dis; 2019 Oct; 69(Suppl 6):S449-S458. PubMed ID: 31665776
[TBL] [Abstract][Full Text] [Related]
31. Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Jayahar Bharathi M; Ramakrishnan R; Ramesh S; Murugan N
Ophthalmic Res; 2012; 47(1):52-6. PubMed ID: 21720185
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital.
Mathur P; Kapil A; Das B; Dhawan B
Indian J Med Res; 2002 Apr; 115():153-7. PubMed ID: 12239838
[TBL] [Abstract][Full Text] [Related]
33. Frequency of extended spectrum β-lactamase producing urinary isolates of Gram-negative bacilli among patients seen in a multispecialty hospital in Vellore district, India.
Nandagopal B; Sankar S; Sagadevan K; Arumugam H; Jesudason MV; Aswathaman K; Nair A
Indian J Med Microbiol; 2015; 33(2):282-5. PubMed ID: 25865984
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal.
Bhandari R; Pant ND; Poudel A; Sharma M
BMC Res Notes; 2016 Aug; 9():390. PubMed ID: 27488224
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
Kader AA; Kumar AK
Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
[TBL] [Abstract][Full Text] [Related]
36. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of extended-spectrum beta-lactamases (ESBLs) produced in blood isolates of gram-negative bacteria in a teaching hospital in southern Thailand.
Jitsurong S; Yodsawat J
Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):131-5. PubMed ID: 16771225
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of methods for AmpC beta-lactamase in gram negative clinical isolates from tertiary care hospitals.
Singhal S; Mathur T; Khan S; Upadhyay DJ; Chugh S; Gaind R; Rattan A
Indian J Med Microbiol; 2005 Apr; 23(2):120-4. PubMed ID: 15928443
[TBL] [Abstract][Full Text] [Related]
40. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
